Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment

Grüenwald V, Merseburger AS

OncoTargets and Therapy 2012, 5:111-117

Published Date: 18 June 2012